David W. Gray

机构：University of Dundee, Drug Discovery Laboratory (Norway) · ORCID：0000-0001-9512-3828

发表论文 116 篇 · 总被引 5101 次 · h-index 33

代表论文

• Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition (2019 · Proceedings of the National Academy of Sciences · 被引 175)
• Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis (2019 · Proceedings of the National Academy of Sciences · 被引 152)
• Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies (2021 · PLoS ONE · 被引 98)
• Targeting N-myristoylation for therapy of B-cell lymphomas (2020 · Nature Communications · 被引 67)
• Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis (2018 · Journal of Medicinal Chemistry · 被引 49)
• Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry (2021 · SLAS DISCOVERY · 被引 46)